Literature DB >> 3071481

Lipoprotein alterations in diabetes mellitus.

G M Kostner1, I Karádi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3071481     DOI： 10.1007/bf00274772

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  69 in total

1.  EPIDEMIOLOGICAL STUDIES OF CARDIOVASCULAR DISEASE IN A TOTAL COMMUNITY--TECUMSEH, MICHIGAN.

Authors:  F H EPSTEIN; L D OSTRANDER; B C JOHNSON; M W PAYNE; N S HAYNER; J B KELLER; T FRANCIS
Journal:  Ann Intern Med       Date:  1965-06       Impact factor: 25.391

2.  Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

Authors:  M J Garcia; P M McNamara; T Gordon; W B Kannel
Journal:  Diabetes       Date:  1974-02       Impact factor: 9.461

3.  Does hyperglycaemia or hyperinsulinaemia characterise the patient with chemical diabetes?

Authors:  G M Reaven; J Olefsky; J W Farquhar
Journal:  Lancet       Date:  1972-06-10       Impact factor: 79.321

4.  The effect of improved diabetic control on plasma lipid and lipoprotein levels: a comparison of conventional therapy and continuous subcutaneous insulin infusion.

Authors:  A Pietri; F L Dunn; P Raskin
Journal:  Diabetes       Date:  1980-12       Impact factor: 9.461

5.  Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism.

Authors:  U P Steinbrecher; J L Witztum
Journal:  Diabetes       Date:  1984-02       Impact factor: 9.461

6.  Human noninsulin-dependent diabetes: identification of a defect in plasma cholesterol transport normalized in vivo by insulin and in vitro by selective immunoadsorption of apolipoprotein E.

Authors:  C J Fielding; G M Reaven; P E Fielding
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

Review 7.  Hyperlipidaemia of diabetes.

Authors:  G F Gibbons
Journal:  Clin Sci (Lond)       Date:  1986-11       Impact factor: 6.124

8.  Diabetes, lipoproteins, and atherosclerosis.

Authors:  G Schonfeld
Journal:  Metabolism       Date:  1985-12       Impact factor: 8.694

9.  Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity.

Authors:  J L Witztum; E M Mahoney; M J Branks; M Fisher; R Elam; D Steinberg
Journal:  Diabetes       Date:  1982-04       Impact factor: 9.461

10.  Serum lipoprotein and lipoprotein lipase in overweight, type II diabetics during and after supplemented fasting.

Authors:  B Vessby; I Selinus; H Lithell
Journal:  Arteriosclerosis       Date:  1985 Jan-Feb
View more
  8 in total

1.  Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy.

Authors:  E Hommel; P Andersen; M A Gall; F Nielsen; B Jensen; P Rossing; J Dyerberg; H H Parving
Journal:  Diabetologia       Date:  1992-05       Impact factor: 10.122

Review 2.  Triglycerides and disease.

Authors:  C A Seymour; C D Byrne
Journal:  Postgrad Med J       Date:  1993-09       Impact factor: 2.401

Review 3.  Assembly and secretion of hepatic very-low-density lipoprotein.

Authors:  G F Gibbons
Journal:  Biochem J       Date:  1990-05-15       Impact factor: 3.857

4.  Chronic exogenous hyperinsulinaemia does not modify the acute inhibitory effect of insulin on the secretion of very-low-density lipoprotein triacylglycerol and apolipoprotein B in primary cultures of rat hepatocytes.

Authors:  C S Bourgeois; D Wiggins; G F Gibbons
Journal:  Biochem J       Date:  1996-02-15       Impact factor: 3.857

5.  Microalbuminuria predicts the development of serum lipoprotein abnormalities favouring atherogenesis in newly diagnosed type 2 (non-insulin-dependent) diabetic patients.

Authors:  L Niskanen; M Uusitupa; H Sarlund; O Siitonen; E Voutilainen; I Penttilä; K Pyörälä
Journal:  Diabetologia       Date:  1990-04       Impact factor: 10.122

6.  Plasma lipoprotein (a) concentration and phenotypes in diabetes mellitus.

Authors:  A Császár; H Dieplinger; C Sandholzer; I Karádi; E Juhász; H Drexel; T Halmos; L Romics; J R Patsch; G Utermann
Journal:  Diabetologia       Date:  1993-01       Impact factor: 10.122

7.  Long-term maintenance of high rates of very-low-density-lipoprotein secretion in hepatocyte cultures. A model for studying the direct effects of insulin and insulin deficiency in vitro.

Authors:  J M Duerden; S M Bartlett; G F Gibbons
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

8.  The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy.

Authors:  M A Gall; F S Nielsen; U M Smidt; H H Parving
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.